Cantor Fitzgerald Starts Dendreon (DNDN) at Hold; Path to Stability
Tweet
Share
E-mailGet Alerts DNDN Hot Sheet
Price: $0.13 --0%
Rating Summary:
2 Buy, 15 Hold, 9 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
2 Buy, 15 Hold, 9 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Cantor Fitzgerald initiates coverage on Dendreon (NASDAQ: DNDN) with a Hold.
Cantor analyst says, "The shares have had ups and downs over the past few years as the market has attempted to value the company's groundbreaking product Provenge, the first therapeutic cancer vaccine. We believe that expectations have come down considerably, but that much heavy lifting still needs to occur to provide a clearer path forward."
"Dendreon's cost structure is not in line with what is normally observed among biotechnology companies, and this has created anxiety over the robustness of profitability. We believe that the company's efficiencies will improve but that this may not occur with consistency for some time."
For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.
Shares of Dendreon closed at $13.97 yesterday.
Cantor analyst says, "The shares have had ups and downs over the past few years as the market has attempted to value the company's groundbreaking product Provenge, the first therapeutic cancer vaccine. We believe that expectations have come down considerably, but that much heavy lifting still needs to occur to provide a clearer path forward."
"Dendreon's cost structure is not in line with what is normally observed among biotechnology companies, and this has created anxiety over the robustness of profitability. We believe that the company's efficiencies will improve but that this may not occur with consistency for some time."
For an analyst ratings summary and ratings history on Dendreon click here. For more ratings news on Dendreon click here.
Shares of Dendreon closed at $13.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- Goldman Sachs Starts Luxshare Precision (2475:HK) at Buy
- BTIG Starts Freenome Inc. (FRNM) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
